Skip to main content

Earlier treatment with biologics to reduce the risk of organ damage

Aug 31, 2024 8:43 am
Sponsored by GSK US Medical Affairs Learn about the importance of reducing organ damage and corticosteroid-associated toxicity in SLE, and how biologics may help to change the course of the disease by targeting its underlying mechanisms.

ADD THE FIRST COMMENT

If you are a health practitioner, you may to comment.

Due to the nature of these comment forums, only health practitioners are allowed to comment at this time.

×